Four articles published in 2021 by the The American Journal of Psychiatry have been honored by the Brain and Behavior Research Foundation as 2021 Leading Research Achievements for notable contributions to research on mental illness and the biology of the brain by its grantees, prizewinners, and scientific council members.

The Brain & Behavior Research Foundation (BBRF) is the world’s largest private funder of mental health research grants to develop improved treatments, cures, and methods of prevention for mental illness.

The four articles honored are:

• “A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder,” Adriana Feder, M.D., et al.
• “Anticholinergic Medication Burden–Associated Cognitive Impairment in Schizophrenia,” Yash B. Joshi, M.D., et al.
• “Neonatal Brain Response to Deviant Auditory Stimuli and Relation to Maternal Trait Anxiety,” Chad M. Sylvester, M.D., et al.
• “Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial,” Eleanor J. Cole, Ph.D., et al.

Published monthly, The American Journal of Psychiatry is the most widely read psychiatric journal in the world.

“We are extremely proud to have these four articles recognized with such a prestigious honor,” said AJP Editor-in-Chief Ned H. Kalin, M.D. “The Journal is committed to publishing the latest advances in the diagnosis and treatment of mental illness, and studies like this ensure that we are making essential contributing scientific conversation on how the brain works.”

American Psychiatric Association

The American Psychiatric Association, founded in 1844, is the oldest medical association in the country. The APA is also the largest psychiatric association in the world with more than 37,400 physician members specializing in the diagnosis, treatment, prevention and research of mental illnesses. APA's vision is to ensure access to quality psychiatric diagnosis and treatment. For more information please visit www.psychiatry.org.